Potential role of tocotrienols in the treatment and prevention of breast cancer

Authors

  • Paul W. Sylvester,

    Corresponding author
    1. Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA
    • Address for correspondence: Dr. Paul W. Sylvester, Ph.D., College of Pharmacy, 700 University Avenue, University of Louisiana at Monroe, Monroe, LA 71209, USA. Tel.: + 318–342-1958; Fax: +318–342-1737; E-mail: sylvester@ulm.edu.

    Search for more papers by this author
  • Mohamed R. Akl,

    1. Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA
    Search for more papers by this author
  • Abhita Malaviya,

    1. Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA
    Search for more papers by this author
  • Parash Parajuli,

    1. Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA
    Search for more papers by this author
  • Suryatheja Ananthula,

    1. Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA
    Search for more papers by this author
  • Roshan V. Tiwari,

    1. Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA
    Search for more papers by this author
  • Nehad M. Ayoub

    1. Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA
    Search for more papers by this author

Abstract

Vitamin E is a generic term that refers to a family of compounds that is further divided into two subgroups called tocopherols and tocotrienols. Although all natural forms of vitamin E display potent antioxidant activity, tocotrienols are significantly more potent than tocopherols in inhibiting tumor cell growth and viability, and anticancer activity of tocotrienols is mediated independently of their antioxidant activity. In addition, the anticancer effects of tocotrienols are observed using treatment doses that have little or no effect on normal cell function or viability. This review will summarize experimental studies that have identified the intracellular mechanism mediating the anticancer effects of tocotrienols. Evidence is also provided showing that combined treatment of tocotrienol with other cancer chemotherapies can result in a synergistic inhibition in cancer cell growth and viability. Taken together, these findings strongly indicate that tocotrienols may provide significant health benefits in the prevention and/or treatment of cancer when used either alone as monotherapy or in combination with other anticancer agents. © 2013 BioFactors, 40(1):49–58, 2014

Ancillary